These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 27575664
21. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW. J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894 [Abstract] [Full Text] [Related]
22. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148 [Abstract] [Full Text] [Related]
28. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M. JAMA; 2001 Dec 19; 286(23):2947-55. PubMed ID: 11743835 [Abstract] [Full Text] [Related]
29. Safety of antidepressant use in pregnant and nursing women. Lamberg L. JAMA; 1999 Jul 21; 282(3):222-3. PubMed ID: 10422977 [No Abstract] [Full Text] [Related]
30. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, Nemeroff CB. J Clin Psychiatry; 2003 Jan 21; 64(1):73-80. PubMed ID: 12590627 [Abstract] [Full Text] [Related]
31. Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression. Reis M, Aberg-Wistedt A, Agren H, Höglund P, Akerblad AC, Bengtsson F. Hum Psychopharmacol; 2004 Jul 21; 19(5):283-91. PubMed ID: 15252820 [Abstract] [Full Text] [Related]
32. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J, van Agteren JE, Carson-Chahhoud KV. Cochrane Database Syst Rev; 2018 Dec 19; 12(12):CD012346. PubMed ID: 30566235 [Abstract] [Full Text] [Related]
33. Neonatal complications after intrauterine exposure to SSRI antidepressants. Prescrire Int; 2004 Jun 19; 13(71):103-4. PubMed ID: 15233148 [Abstract] [Full Text] [Related]
34. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Orsolini L, Bellantuono C. Hum Psychopharmacol; 2015 Jan 19; 30(1):4-20. PubMed ID: 25572308 [Abstract] [Full Text] [Related]
35. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. J Clin Psychiatry; 2004 Feb 19; 65(2):230-7. PubMed ID: 15003078 [Abstract] [Full Text] [Related]
36. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine. Uguz F. J Hum Lact; 2015 Aug 19; 31(3):371-3. PubMed ID: 25896469 [Abstract] [Full Text] [Related]
37. Using sertraline in postpartum and breastfeeding: balancing risks and benefits. Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, Beccarini Crescenzi B, Bolognesi S, Goracci A, Coluccia A, Ferretti F, Fagiolini A. Expert Opin Drug Saf; 2018 Jul 19; 17(7):719-725. PubMed ID: 29927667 [Abstract] [Full Text] [Related]
38. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Muijsers RB, Plosker GL, Noble S. Drugs Aging; 2002 Jul 19; 19(5):377-92. PubMed ID: 12093324 [Abstract] [Full Text] [Related]